Jagannath S - Search Results

1

Efficacy of Intravenous Immunoglobulin for Preventing Infections in Patients with Multiple Myeloma.

Lancman G, Lozada K, Athar N, Jacobs S, Doucette J, Cho HJ, Jagannath S, Madduri D, Parekh S, Richard S, Richter J, Chari A. Lancman G, et al. Among authors: jagannath s. Clin Lymphoma Myeloma Leuk. 2021 May;21(5):e470-e476. doi: 10.1016/j.clml.2020.12.026. Epub 2021 Feb 7. Clin Lymphoma Myeloma Leuk. 2021. PMID: 33716054

2

The role of thalidomide in multiple myeloma.

Schwab C, Jagannath S. Schwab C, et al. Among authors: jagannath s. Clin Lymphoma Myeloma. 2006 Jul;7(1):26-9. doi: 10.3816/CLM.2006.n.035. Clin Lymphoma Myeloma. 2006. PMID: 16879766 Review.

3

Repeated complete responses with bortezomib in a heavily pretreated primary refractory patient with light chain multiple myeloma.

Bhandari M, Jagannath S. Bhandari M, et al. Among authors: jagannath s. Clin Lymphoma Myeloma. 2007 Mar;7(5):373-5. doi: 10.3816/CLM.2007.n.016. Clin Lymphoma Myeloma. 2007. PMID: 17562249

4

Current standards for first-line therapy of multiple myeloma.

Jagannath S. Jagannath S. Clin Lymphoma Myeloma. 2007 Aug;7 Suppl 5:S207-14. doi: 10.3816/clm.2007.s.024. Clin Lymphoma Myeloma. 2007. PMID: 17877846 Review.

5

Progress in multiple myeloma.

Jagannath S. Jagannath S. Clin Lymphoma Myeloma. 2008 Aug;8(4):202-4. doi: 10.3816/CLM.2008.n.027. Clin Lymphoma Myeloma. 2008. PMID: 18765306 No abstract available.

6

Treatment of patients with myeloma with comorbid conditions: considerations for the clinician.

Jagannath S. Jagannath S. Clin Lymphoma Myeloma. 2008 Aug;8 Suppl 4:S149-56. doi: 10.3816/CLM.2008.s.011. Clin Lymphoma Myeloma. 2008. PMID: 18952546 Review.

7

Phase III randomised study of dexamethasone with or without oblimersen sodium for patients with advanced multiple myeloma.

Chanan-Khan AA, Niesvizky R, Hohl RJ, Zimmerman TM, Christiansen NP, Schiller GJ, Callander N, Lister J, Oken M, Jagannath S. Chanan-Khan AA, et al. Among authors: jagannath s. Leuk Lymphoma. 2009 Apr;50(4):559-65. doi: 10.1080/10428190902748971. Leuk Lymphoma. 2009. PMID: 19373653 Clinical Trial.

8

Cellular immune responses against CT7 (MAGE-C1) and humoral responses against other cancer-testis antigens in multiple myeloma patients.

Lendvai N, Gnjatic S, Ritter E, Mangone M, Austin W, Reyner K, Jayabalan D, Niesvizky R, Jagannath S, Bhardwaj N, Chen-Kiang S, Old LJ, Cho HJ. Lendvai N, et al. Among authors: jagannath s. Cancer Immun. 2010 Jan 29;10:4. Cancer Immun. 2010. PMID: 20108890 Free PMC article.

9

The current status and future of multiple myeloma in the clinic.

Jagannath S, Kyle RA, Palumbo A, Siegel DS, Cunningham S, Berenson J. Jagannath S, et al. Clin Lymphoma Myeloma Leuk. 2010 Feb;10(1):28-43. doi: 10.3816/CLML.2010.n.003. Clin Lymphoma Myeloma Leuk. 2010. PMID: 20223727 Review.

10

Vorinostat plus bortezomib for the treatment of relapsed/refractory multiple myeloma: a case series illustrating utility in clinical practice.

Mazumder A, Vesole DH, Jagannath S. Mazumder A, et al. Among authors: jagannath s. Clin Lymphoma Myeloma Leuk. 2010 Apr;10(2):149-51. doi: 10.3816/CLML.2010.n.022. Clin Lymphoma Myeloma Leuk. 2010. PMID: 20371450

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

514 results

Search Page

Filters